HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 48 filers reported holding HOOKIPA PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2 | 0.0% | 2,747 | 0.0% | 0.00% | – |
Q4 2022 | $2 | -100.0% | 2,747 | -67.8% | 0.00% | – |
Q3 2022 | $11,000 | -21.4% | 8,524 | 0.0% | 0.00% | – |
Q2 2022 | $14,000 | -46.2% | 8,524 | -26.8% | 0.00% | – |
Q1 2022 | $26,000 | -82.4% | 11,644 | -81.7% | 0.00% | – |
Q4 2021 | $148,000 | +54.2% | 63,644 | +288.8% | 0.00% | – |
Q3 2021 | $96,000 | +336.4% | 16,368 | +573.9% | 0.00% | – |
Q2 2021 | $22,000 | -92.1% | 2,429 | -88.3% | 0.00% | – |
Q1 2021 | $278,000 | +97.2% | 20,683 | +63.1% | 0.00% | – |
Q4 2020 | $141,000 | +4.4% | 12,678 | -11.5% | 0.00% | – |
Q3 2020 | $135,000 | -24.6% | 14,330 | -6.8% | 0.00% | – |
Q2 2020 | $179,000 | +539.3% | 15,379 | +364.2% | 0.00% | – |
Q1 2020 | $28,000 | -77.0% | 3,313 | -66.8% | 0.00% | – |
Q4 2019 | $122,000 | +1120.0% | 9,970 | +711.2% | 0.00% | – |
Q3 2019 | $10,000 | -54.5% | 1,229 | -62.1% | 0.00% | – |
Q2 2019 | $22,000 | – | 3,242 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 530,245 | $3,569,000 | 2.36% |
Redmile Group, LLC | 1,891,879 | $12,732,000 | 0.36% |
Artal Group S.A. | 1,134,616 | $7,636,000 | 0.31% |
DC Investments Management, LLC | 42,857 | $288,000 | 0.16% |
Hillhouse Capital Management | 657,540 | $4,425,000 | 0.14% |
HHLR ADVISORS, LTD. | 285,714 | $1,923,000 | 0.04% |
Baker Brothers Advisors | 892,857 | $6,009,000 | 0.04% |
Tower Research Capital LLC (TRC) | 6,011 | $40,000 | 0.00% |
Artisan Partners Limited Partnership | 126,273 | $850,000 | 0.00% |
SALEM INVESTMENT COUNSELORS INC | 900 | $6,000 | 0.00% |